Zimmer Biomet secures $2.75B in new revolving credit facilities, replaces 2025 agreements

Filed June 29, 2026 · Period ending June 26, 2026 · ~1 min read

Key Changes

• high

  Entered $1.5B five-year unsecured revolving facility maturing June 2031, with option to extend two years and increase by $750M; replaces 2025 five-year agreement with no principal outstanding.

  Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
• medium

  Added $1.25B 364-day unsecured revolving facility maturing June 2027 for general corporate purposes; replaces 2025 364-day agreement.

  Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
• medium

  Both facilities require debt-to-EBITDA ratio ≤4.5x (temporarily 5.0x post-acquisition), with interest at SOFR plus credit-rating-based margin.

  Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →